Filing Flows › CVS Health (CVS) › Q3 2026 › vs Q2 2026
CVS Health (CVS) Q3 2026 vs Q2 2026 (quarter over quarter)
CVS Health's revenue rose $2.3B (+2%) from $106.1B in Q2 2026 to $108.4B in Q3 2026. Operating margin 3.3% against 4.4% (-1.1 pts).
CVS Health, Q3 2026: revenue $108.4B (+5% year over year), operating margin 3.3%, net earnings $2.2B, operating cash flow $4.7B. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Operating margin | 3.3% | 4.4% | -1.1 pts |
| Net margin | 2.0% | 2.8% | -0.8 pts |
| Free cash flow margin | 3.6% | 5.3% | -1.7 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $108.4B | $106.1B | $2.3B | +2% |
| Operating profit | $3.6B | $4.7B | −$1.1B | -24% |
| Costs & expenses | $104.8B | $101.4B | $3.4B | +3% |
| Pre-tax earnings | $2.8B | $4.0B | −$1.1B | -28% |
| Other expense, net | $717M | $726M | −$9.0M | -1% |
| Cost of revenue | $61.2B | $58.9B | $2.3B | +4% |
| Other operating costs | $43.6B | $42.5B | $1.1B | +3% |
| Net earnings | $2.2B | $3.0B | −$824M | -28% |
| Income tax | $678M | $982M | −$304M | -31% |
| Depreciation & amortization | $1.1B | $1.1B | $6.0M | +0.5% |
| Share-based compensation | $168M | $176M | −$8.0M | -5% |
| Working capital & other | $1.3B | $2.0B | −$795M | -39% |
| Operating cash flow | $4.7B | $6.3B | −$1.6B | -26% |
| Free cash flow (OCF − capex) | $3.9B | $5.7B | −$1.7B | -31% |
| Capital expenditures | $817M | $691M | $126M | +18% |
Questions
How much did CVS Health's revenue grow quarter over quarter in Q3 2026?
CVS Health's revenue rose $2.3B (+2%) from $106.1B in Q2 2026 to $108.4B in Q3 2026. Operating margin 3.3% against 4.4% (-1.1 pts).